Kiora Pharmaceuticals (KPRX) Receivables - Other (2016 - 2018)
Kiora Pharmaceuticals (KPRX) has disclosed Receivables - Other for 4 consecutive years, with $922488.0 as the latest value for Q1 2018.
- For the quarter ending Q1 2018, Receivables - Other rose 739.89% year-over-year to $922488.0, compared with a TTM value of $922488.0 through Mar 2018, up 739.89%, and an annual FY2016 reading of $37349.0, down 95.88% over the prior year.
- Receivables - Other was $922488.0 for Q1 2018 at Kiora Pharmaceuticals, up from $602000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $922488.0 in Q1 2018 and bottomed at $37349.0 in Q4 2016.
- Average Receivables - Other over 4 years is $349564.9, with a median of $146078.0 recorded in 2017.
- The sharpest move saw Receivables - Other crashed 95.88% in 2016, then surged 1511.78% in 2017.
- Year by year, Receivables - Other stood at $907500.0 in 2015, then plummeted by 95.88% to $37349.0 in 2016, then skyrocketed by 1511.82% to $602000.0 in 2017, then surged by 53.24% to $922488.0 in 2018.
- Business Quant data shows Receivables - Other for KPRX at $922488.0 in Q1 2018, $602000.0 in Q3 2017, and $146078.0 in Q2 2017.